Harvard Bioscience Inc (HBIO): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2011-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

Older than the company's other figures. The latest EBITDA is for the year ended 2012-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.

$12.04M
Year ended 2012-12-31
$14.13M2010-12-31: $14.13M2011-12-31: $12.73M2012-12-31: $12.04M$12.04M
2010-12-31 EBITDA (USD) 2012-12-31
Period endedEBITDAChange YoYSource filing
2012-12-31$12.04M-5.5%2015-03-12, From 2012-01-01
2011-12-31$12.73Mn/c2014-03-14, From 2011-01-01
2010-12-31$14.13Mn/a2013-03-18, From 2010-01-01